Giant Condyloma Acuminata in Indonesian Females with SLE under Immunosuppressant and Steroid Therapy

Abstract EN

Introduction.

Immunosuppressant and steroid therapy in systemic lupus erythematosus (SLE) increases the risk of human papillomavirus (HPV) infections, one of which is giant condyloma acuminata (GCA).

To our knowledge, there is no report evaluating the correlation between immunosuppressive and steroid therapy in patients with SLE and the prevalence of GCA.

Case Report.

A 42-year-old female was diagnosed with SLE a year ago and has been treated with steroids and immunosuppressive drugs.

In the last few months she presented GCA involving the genital area recurring almost every two months.

Type 6 and 11 HPVs were identified in vulva, vagina, and cervix.

Methods.

PubMed, EBSCO, and Cochrane Library literature were searched from inception to July 2015.

Authors screened all titles and abstracts and read full text article, and two case-control studies were found relevant.

Results.

SLE patients in both studies were under immunosuppressive and steroid therapy.

Condyloma acuminata was diagnosed at 108 months (latest) and 1 month (earliest) after SLE.

Type 6, 11, 16, 42, and oncogenic group of HPV were identified.

Conclusions.

GCA is a type of HPV infection seldom observed in SLE patients.

Therefore, their correlation is still unclear.

Period of time since SLE was diagnosed and GCA varies from months to years.

A more thorough physical and laboratory examination leading to HPV and other infectious disease is recommended.